GGrantIndex
Sort

50,496 grants matching lung cancer

Macro-vasculature: A Novel Image Biomarker of Lung Cance

$411,709
Jiantao Pu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

Discovery of Anticancer Drugs from Cyanophytes

$411,707
Frederick Augustus Valeriote · Henry Ford Health System · R01 · FY2009 · CA

Arsenic Exposure and Birth Outcomes in Bangladesh

$411,675
David C Christiani · Harvard School Of Public Health · R01 · FY2008 · ES

NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma

$411,644
Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2014 · CA

AIDS and Cancer Specimen Resource (ACSR)

$411,640
Jeffrey M Bethony · George Washington University · UM1 · FY2025 · CA

Serum Antibody Profiling with a Carbohydrate Microarray

$411,634
Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Development and application of non-thermal high frequency IRE to treat hepatic tumors

$411,633
Rafael Vidal Davalos · Georgia Institute Of Technology · R01 · FY2024 · CA

Pharmacogenetic Studies

$411,619
Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA

Regulation of stem-like CD8+ T cells and their role in immunotherapy

$411,598
Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2021 · CA

Ethanol Effects on Recovery after Injury

$411,594
Elizabeth J Kovacs · Loyola University Chicago · R01 · FY2011 · AA

Vaccine and radiation for the therapy of human cancers

$411,584
James Hodge · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

SCREENING CHEMOPREVENTIVE AGENTS IN MICE WITH GREMLINE M

$411,584
Ohio State University · N01 · FY2000 · CN

Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis

$411,504
Yun Wu · State University Of New York At Buffalo · R33 · FY2015 · CA

Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor

$411,481
Bruce R Zetter · Boston Children'S Hospital · R01 · FY2018 · CA

Risk prediction of breast cancer treatment-related cardiotoxicity to guide clinical decision making

$411,468
Reina Haque · Kaiser Foundation Research Institute · R01 · FY2020 · HL

Enhancing cancer treatment by normal tissue protection

$411,463
Eliot M Rosen · Georgetown University · R01 · FY2014 · CA

Synaptic and circuit mechanisms of olfactory processing

$411,461
Rachel Wilson · Harvard Medical School · R01 · FY2007 · DC

Extracellular Matrix in the Innate Immune Response in Lung Inflammation

$411,439
Thomas N Wight · Benaroya Research Inst At Virginia Mason · P01 · FY2014 · HL

Project 1: Targeting Tumor Phospholipase PLA2G10 for Cancer Immunotherapy

$411,417
Kurt A Schalper · Yale University · P50 · FY2025 · CA

GENES WITH SIGNIFICANT DEFICIT OF LOSS-OF-FUNCTION MUTATIONS IN LUNG TUMOR

$411,404
Ivan P Gorlov · Baylor College Of Medicine · R21 · FY2025 · CA

Decoding and targeting saccharopine pathway in cancer metastasis

$411,390
Sumin Kang · Emory University · R01 · FY2023 · CA

Community Outreach and Engagement

$411,370
Lourdes Baezconde Garbanati · University Of Southern California · P30 · FY2023 · CA

In utero and childhood exposure to arsenic in water and lifelong lung disease

$411,364
Craig M Steinmaus · University Of California Berkeley · R01 · FY2011 · ES

NONINVASIVE PERSONALIZATION OF LUNG CANCER THERAPY USING A NEW, CLINICAL-GRADE ASSAY FOR PLASMA-BASED MEASUREMENT AND MONITORING OF TUMOR GENOTYPE

$411,305
Dana-Farber Cancer Institute, Inc. · · FY2014 · Department of the Army

Project-004

$411,284
Kunle O Odunsi · University Of Chicago · P30 · FY2023 · CA